| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,846,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,268,249 |
|
|
|
Indirect Value
|
$149,961,660 |
|
|
| Total
Shares |
10,589,900 |
|
|
| Total
Value |
$151,229,909 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-05-29 |
16,000 |
2024-05-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-02-05 |
4 |
OE |
$5.63 |
$398,749 |
D/D |
59,200 |
244,258 |
|
- |
|
| GILD |
Gilead Sciences Inc |
officerTitle |
• – – |
2003-08-05 |
4 |
OE |
$4.50 |
$445,250 |
D/D |
75,020 |
237,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-07-07 |
4 |
AS |
$119.39 |
$446,400 |
D/D |
(3,739) |
165,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-11-12 |
4 |
OE |
$16.01 |
$480,300 |
D/D |
30,000 |
1,080,156 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$497,092 |
D/D |
(7,070) |
24,011 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-03-06 |
4 |
D |
$45.40 |
$568,544 |
D/D |
(12,523) |
2,159,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2010-03-08 |
4 |
D |
$47.01 |
$570,513 |
D/D |
(12,136) |
1,052,346 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$570,559 |
D/D |
(7,071) |
28,995 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-05-05 |
4 |
OE |
$9.50 |
$617,500 |
D/D |
65,000 |
267,058 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-18 |
4 |
B |
$3.72 |
$768,046 |
D/D |
206,198 |
509,609 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-10-25 |
4 |
OE |
$7.40 |
$839,805 |
D/D |
113,496 |
605,069 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, Research |
• – – |
2004-08-11 |
4 |
OE |
$6.53 |
$908,285 |
D/D |
65,000 |
267,058 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-08-17 |
4 |
OE |
$7.30 |
$913,832 |
D/D |
123,704 |
601,573 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2007-10-26 |
4/A |
S |
$46.37 |
$927,461 |
I/I |
(20,000) |
154,944 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-15 |
4 |
B |
$0.80 |
$1,102,718 |
D/D |
1,370,688 |
2,180,297 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-19 |
4 |
B |
$3.78 |
$1,134,510 |
D/D |
300,000 |
809,609 |
2.81 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-01-15 |
4 |
OE |
$16.40 |
$1,147,650 |
D/D |
70,000 |
189,302 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2015-02-17 |
4 |
OE |
$16.40 |
$1,147,650 |
D/D |
70,000 |
235,168 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Research |
• – – |
2005-02-15 |
4 |
OE |
$7.30 |
$1,213,445 |
D/D |
166,296 |
614,478 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2009-05-21 |
4 |
S |
$42.64 |
$1,279,341 |
I/I |
(30,000) |
14,394 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-07-15 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
2,249,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-08-14 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
2,249,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-09-16 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
2,249,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-10-14 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
2,249,643 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• – – |
2013-11-14 |
4 |
OE |
$14.50 |
$1,305,225 |
D/D |
90,000 |
90,000 |
0 |
- |
|
193 Records found
|
|
Page 4 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
